Compositions, and methods of using such compositions, useful for placement, for example injection, into the interior of human or animal eyes are provided. Such compositions include a therapeutic component, such as one or more corticosteroids, a biocompatible polymeric component, and a
solvent component. The composition is in a fluid form before placement in the interior of an eye, and becomes less fluid after the composition is placed in the eye to form an extended or delayed release
drug delivery element or
system. The
drug delivery element is formed by the dissipation of the
solvent from the composition when the composition is placed in the interior of an eye. One example of a composition includes
triamcinolone acetonide as a therapeutic agent. A method of treating an ophthalmic condition, or otherwise improving or enhancing vision of a patient, comprises placing the
fluid composition in the interior of the eye. The method may be practiced by injecting the
fluid composition into the interior of the eye.